COVID-19 Clinical Trials and Racial Disproportionality
Figure 1: A doctor drawing blood from a patient as part of the Tuskegee Syphilis Study in 1932, National Archives (National Archives, 1932) Source: Wikimedia Commons Despite disproportionately higher rates of COVID-19 infection, hospitalization, and death in racial and ethnic minority groups, these vulnerable populations remain heavily underrepresented in COVID-19 clinical trials. Currently, Black, Latinx, …
COVID-19 Clinical Trials and Racial Disproportionality Read More »







